Response to the Letter Regarding “Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis”
Hepatology Research · 2026-11 · 56 (11) · 1765-1766
DOI: 10.1111/hepr.70236 ↗Kurz gefasst
Leserbrief in der Zeitschrift Hepatology Research, online erschienen am 03.07.2026. Verfasst von Masahiko Tameda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Mie, Japan. Die Arbeit nennt 8 Literaturangaben. Gefördert von: JSPS KAKENHI, AMED.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
ORCID-Profile: Masahiko Tameda, Hayato Nakagawa
Förderung
- JSPS KAKENHI
- AMED
Zitieren
APA
Tameda, M., & Nakagawa, H. (2026). Response to the Letter Regarding “Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis”. Hepatology Research, 56(11), 1765-1766. https://doi.org/10.1111/hepr.70236
Vancouver
Tameda M, Nakagawa H. Response to the Letter Regarding “Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis”. Hepatology Research. 2026;56(11):1765-1766. doi:10.1111/hepr.70236
BibTeX
@article{Tameda2026,
author = {Tameda, Masahiko and Nakagawa, Hayato},
title = {Response to the Letter Regarding “Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis”},
journal = {Hepatology Research},
year = {2026},
volume = {56},
number = {11},
pages = {1765--1766},
doi = {10.1111/hepr.70236}
}
EUVIMED